237 related articles for article (PubMed ID: 26688279)
1. Immunogenicity and protective efficacy of Clostridium difficile spore proteins.
Ghose C; Eugenis I; Edwards AN; Sun X; McBride SM; Ho DD
Anaerobe; 2016 Feb; 37():85-95. PubMed ID: 26688279
[TBL] [Abstract][Full Text] [Related]
2. Clostridium difficile exosporium cysteine-rich proteins are essential for the morphogenesis of the exosporium layer, spore resistance, and affect C. difficile pathogenesis.
Calderón-Romero P; Castro-Córdova P; Reyes-Ramírez R; Milano-Céspedes M; Guerrero-Araya E; Pizarro-Guajardo M; Olguín-Araneda V; Gil F; Paredes-Sabja D
PLoS Pathog; 2018 Aug; 14(8):e1007199. PubMed ID: 30089172
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliC.
Ghose C; Eugenis I; Sun X; Edwards AN; McBride SM; Pride DT; Kelly CP; Ho DD
Emerg Microbes Infect; 2016 Feb; 5(2):e8. PubMed ID: 26839147
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Chicken IgY Specific to
Pizarro-Guajardo M; Díaz-González F; Álvarez-Lobos M; Paredes-Sabja D
Front Cell Infect Microbiol; 2017; 7():365. PubMed ID: 28856119
[No Abstract] [Full Text] [Related]
5. Immunogenic properties of the surface layer precursor of Clostridium difficile and vaccination assays in animal models.
Bruxelle JF; Mizrahi A; Hoys S; Collignon A; Janoir C; Péchiné S
Anaerobe; 2016 Feb; 37():78-84. PubMed ID: 26505926
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.
Tian JH; Glenn G; Flyer D; Zhou B; Liu Y; Sullivan E; Wu H; Cummings JF; Elllingsworth L; Smith G
Vaccine; 2017 Jul; 35(33):4079-4087. PubMed ID: 28669616
[TBL] [Abstract][Full Text] [Related]
7. Oral Immunization with Nontoxigenic Clostridium difficile Strains Expressing Chimeric Fragments of TcdA and TcdB Elicits Protective Immunity against C. difficile Infection in Both Mice and Hamsters.
Wang Y; Wang S; Bouillaut L; Li C; Duan Z; Zhang K; Ju X; Tzipori S; Sonenshein AL; Sun X
Infect Immun; 2018 Nov; 86(11):. PubMed ID: 30150259
[TBL] [Abstract][Full Text] [Related]
8. The recombinant Lactococcus lactis oral vaccine induces protection against C. difficile spore challenge in a mouse model.
Guo S; Yan W; McDonough SP; Lin N; Wu KJ; He H; Xiang H; Yang M; Moreira MA; Chang YF
Vaccine; 2015 Mar; 33(13):1586-95. PubMed ID: 25698490
[TBL] [Abstract][Full Text] [Related]
9. A novel fusion protein containing the receptor binding domains of C. difficile toxin A and toxin B elicits protective immunity against lethal toxin and spore challenge in preclinical efficacy models.
Tian JH; Fuhrmann SR; Kluepfel-Stahl S; Carman RJ; Ellingsworth L; Flyer DC
Vaccine; 2012 Jun; 30(28):4249-58. PubMed ID: 22537987
[TBL] [Abstract][Full Text] [Related]
10. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.
Karczewski J; Zorman J; Wang S; Miezeiewski M; Xie J; Soring K; Petrescu I; Rogers I; Thiriot DS; Cook JC; Chamberlin M; Xoconostle RF; Nahas DD; Joyce JG; Bodmer JL; Heinrichs JH; Secore S
Vaccine; 2014 May; 32(24):2812-8. PubMed ID: 24662701
[TBL] [Abstract][Full Text] [Related]
11. Protein composition of the outermost exosporium-like layer of Clostridium difficile 630 spores.
Díaz-González F; Milano M; Olguin-Araneda V; Pizarro-Cerda J; Castro-Córdova P; Tzeng SC; Maier CS; Sarker MR; Paredes-Sabja D
J Proteomics; 2015 Jun; 123():1-13. PubMed ID: 25849250
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the collagen-like exosporium protein, BclA1, of Clostridium difficile spores.
Pizarro-Guajardo M; Olguín-Araneda V; Barra-Carrasco J; Brito-Silva C; Sarker MR; Paredes-Sabja D
Anaerobe; 2014 Feb; 25():18-30. PubMed ID: 24269655
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the Adherence of
Mora-Uribe P; Miranda-Cárdenas C; Castro-Córdova P; Gil F; Calderón I; Fuentes JA; Rodas PI; Banawas S; Sarker MR; Paredes-Sabja D
Front Cell Infect Microbiol; 2016; 6():99. PubMed ID: 27713865
[No Abstract] [Full Text] [Related]
14. Germinant Synergy Facilitates Clostridium difficile Spore Germination under Physiological Conditions.
Kochan TJ; Shoshiev MS; Hastie JL; Somers MJ; Plotnick YM; Gutierrez-Munoz DF; Foss ED; Schubert AM; Smith AD; Zimmerman SK; Carlson PE; Hanna PC
mSphere; 2018 Sep; 3(5):. PubMed ID: 30185513
[No Abstract] [Full Text] [Related]
15. Identification of Clostridium difficile Immunoreactive Spore Proteins of the Epidemic Strain R20291.
Pizarro-Guajardo M; Ravanal MC; Paez MD; Callegari E; Paredes-Sabja D
Proteomics Clin Appl; 2018 Sep; 12(5):e1700182. PubMed ID: 29573213
[TBL] [Abstract][Full Text] [Related]
16. A Clostridium difficile-Specific, Gel-Forming Protein Required for Optimal Spore Germination.
Donnelly ML; Li W; Li YQ; Hinkel L; Setlow P; Shen A
mBio; 2017 Jan; 8(1):. PubMed ID: 28096487
[TBL] [Abstract][Full Text] [Related]
17. Ultrastructural Variability of the Exosporium Layer of Clostridium difficile Spores.
Pizarro-Guajardo M; Calderón-Romero P; Castro-Córdova P; Mora-Uribe P; Paredes-Sabja D
Appl Environ Microbiol; 2016 Feb; 82(7):2202-2209. PubMed ID: 26850296
[TBL] [Abstract][Full Text] [Related]
18. Expression and display of Clostridium difficile protein FliD on the surface of Bacillus subtilis spores.
Negri A; Potocki W; Iwanicki A; Obuchowski M; Hinc K
J Med Microbiol; 2013 Sep; 62(Pt 9):1379-1385. PubMed ID: 23475909
[TBL] [Abstract][Full Text] [Related]
19. New insights for vaccine development against Clostridium difficile infections.
Pizarro-Guajardo M; Chamorro-Veloso N; Vidal RM; Paredes-Sabja D
Anaerobe; 2019 Aug; 58():73-79. PubMed ID: 31034928
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 5-dependent immunogenicity and protective efficacy of a recombinant fusion protein vaccine containing the nontoxic domains of Clostridium difficile toxins A and B and Salmonella enterica serovar typhimurium flagellin in a mouse model of Clostridium difficile disease.
Ghose C; Verhagen JM; Chen X; Yu J; Huang Y; Chenesseau O; Kelly CP; Ho DD
Infect Immun; 2013 Jun; 81(6):2190-6. PubMed ID: 23545305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
